Vestigial Like 3 (VGLL3) (Middle Region) Peptid
Kurzübersicht für Vestigial Like 3 (VGLL3) (Middle Region) Peptid (ABIN8115723)
Target
Quelle
Applikation
-
-
Protein Region
- Middle Region
-
Verwendungszweck
- VGLL3 Peptide - middle region
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-VGLL3 antibody ( ARP55341_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- VGLL3 (Vestigial Like 3 (VGLL3))
-
Hintergrund
-
Background Information: VGLL3 belongs to the vestigial family. It may act as a specific coactivator for the mammalian TEFs.
Alternative Symbols: DKFZp686O1845, FLJ38507, VGL-3, VGL3
-
Molekulargewicht
- 36kDa
-
Gen-ID
- 389136
-
NCBI Accession
- NP_057290
-
UniProt
- A8MV65
Target
-